8QVA
Hexameric HIV-1 CA in complex with DDD01829894
Summary for 8QVA
Entry DOI | 10.2210/pdb8qva/pdb |
Related | 5HGM 8QUB 8QUH 8QUI 8QUJ 8QUK 8QUL 8QUW 8QUX 8QUY 8QV1 8QV4 8QV9 |
Descriptor | Spacer peptide 1, 1,2-ETHANEDIOL, 7-azanyl-3-(phenylmethyl)-1~{H}-benzimidazol-2-one, ... (4 entities in total) |
Functional Keywords | capsid, viral protein |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 1 |
Total formula weight | 25824.68 |
Authors | Petit, A.P.,Fyfe, P.K. (deposition date: 2023-10-17, release date: 2024-03-27, Last modification date: 2024-07-10) |
Primary citation | Lang, S.,Fletcher, D.A.,Petit, A.P.,Luise, N.,Fyfe, P.,Zuccotto, F.,Porter, D.,Hope, A.,Bellany, F.,Kerr, C.,Mackenzie, C.J.,Wyatt, P.G.,Gray, D.W. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments. Chemmedchem, 19:e202400025-e202400025, 2024 Cited by PubMed: 38581280DOI: 10.1002/cmdc.202400025 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)